B-Lymphocytic Leukemia, Chronic
3 clinical trials · Condition
◉ Watch B-Lymphocytic Leukemia, Chronic
| Record | Firm | Date |
|---|---|---|
| Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT03204188) | National Heart, Lung, and Blood Institute (NHLBI) | 2017-09-22 |
| A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors (NCT02440685) | Asana BioSciences | 2015-05-01 |
Track B-Lymphocytic Leukemia, Chronic automatically
Every clearance here is in the API, with alerts when new ones post.